Literature DB >> 10780974

Characterization of the ATPase released during sympathetic nerve stimulation of the guinea-pig isolated vas deferens.

T D Westfall1, S Sarkar, N Ramphir, D P Westfall, P Sneddon, C Kennedy.   

Abstract

The release of ATPase activity evoked by electrical field stimulation (EFS) (8 Hz, 25 s) was investigated in several tissues in which adenosine 5'-triphosphate (ATP) acts as a neurotransmitter. Superfusate collected during EFS of sympathetic nerves of the guinea-pig, rat and mouse isolated vas deferens and parasympathetic nerves of the guinea-pig isolated urinary bladder contained ATPase activity. ATP breakdown was fastest in superfusate collected from the guinea-pig isolated vas deferens. However, EFS of the enteric nerves of the guinea-pig isolated taenia coli did not release any detectable ATPase. The ATPase released from the guinea-pig isolated vas deferens metabolized ATP at similar rates at incubation temperatures of 37 degrees C and 20 degrees C. Lineweaver-Burke analysis of the initial rates of ATP hydrolysis gave a K(M) of 39 microM and a V(max) of 1039 pmol ATP metabolized min(-1) ml(-1) superfusate. 6-N,N-diethyl-D-beta,gamma-dibromomethyleneATP (ARL 67156), pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) and pyridoxal-5'-phosphate (P-5-P) all inhibited the ATPase activity in a concentration-dependent manner with a potency order of ARL 67156 = PPADS>P-5-P. In conclusion, EFS of several tissues in which ATP is a neurotransmitter causes the release of an ATPase and activity is greatest in the guinea-pig vas deferens. The enzyme has pharmacological and kinetic characteristics that are similar to ectonucleoside triphosphate diphosphohydrolases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780974      PMCID: PMC1572024          DOI: 10.1038/sj.bjp.0703271

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.

Authors:  G Lambrecht; T Friebe; U Grimm; U Windscheif; E Bungardt; C Hildebrandt; H G Bäumert; G Spatz-Kümbel; E Mutschler
Journal:  Eur J Pharmacol       Date:  1992-07-07       Impact factor: 4.432

Review 2.  Ecto-nucleotidases--molecular structures, catalytic properties, and functional roles in the nervous system.

Authors:  H Zimmermann; N Braun
Journal:  Prog Brain Res       Date:  1999       Impact factor: 2.453

Review 3.  Purinergic nerves.

Authors:  G Burnstock
Journal:  Pharmacol Rev       Date:  1972-09       Impact factor: 25.468

Review 4.  Neurotransmitter transporters: recent progress.

Authors:  S G Amara; M J Kuhar
Journal:  Annu Rev Neurosci       Date:  1993       Impact factor: 12.449

5.  Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells.

Authors:  P Heine; N Braun; A Heilbronn; H Zimmermann
Journal:  Eur J Biochem       Date:  1999-05

6.  Concomitant blockade of P2X-receptors and ecto-nucleotidases by P2-receptor antagonists: functional consequences in rat vas deferens.

Authors:  R Bültmann; M Trendelenburg; F Tuluc; H Wittenburg; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-04       Impact factor: 3.000

7.  CD39-L4 is a secreted human apyrase, specific for the hydrolysis of nucleoside diphosphates.

Authors:  J J Mulero; G Yeung; S T Nelken; J E Ford
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

8.  Functional expression of a cDNA encoding a human ecto-ATPase.

Authors:  J Mateo; T K Harden; J L Boyer
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

9.  Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.

Authors:  C H Hoyle; G E Knight; G Burnstock
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

10.  Investigation of the actions of PPADS, a novel P2x-purinoceptor antagonist, in the guinea-pig isolated vas deferens.

Authors:  G J McLaren; G Lambrecht; E Mutschler; H G Bäumert; P Sneddon; C Kennedy
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

View more
  7 in total

1.  Release of a soluble ATPase from the rabbit isolated vas deferens during nerve stimulation.

Authors:  T D Westfall; J R Menzies; R Liberman; S Waterston; N Ramphir; D P Westfall; P Sneddon; C Kennedy
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

2.  Distinct mechanisms underlying alpha1-adrenoceptor and P2x purinoceptor operated ATP release and contraction in the guinea-pig vas deferens.

Authors:  B Sperlágh; P Illes; Z Gerevich; A Köfalvi
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 3.  Neuronal and non-neuronal modulation of sympathetic neurovascular transmission.

Authors:  H Macarthur; G H Wilken; T C Westfall; L L Kolo
Journal:  Acta Physiol (Oxf)       Date:  2011-03-01       Impact factor: 6.311

4.  Adenosine 5-diphosphate-ribose is a neural regulator in primate and murine large intestine along with β-NAD(+).

Authors:  Leonie Durnin; Sung Jin Hwang; Sean M Ward; Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

5.  Rat pancreas secretes particulate ecto-nucleotidase CD39.

Authors:  Christiane E Sørensen; Jan Amstrup; Hans N Rasmussen; Ieva Ankorina-Stark; Ivana Novak
Journal:  J Physiol       Date:  2003-06-27       Impact factor: 5.182

Review 6.  The purinergic neurotransmitter revisited: a single substance or multiple players?

Authors:  Violeta N Mutafova-Yambolieva; Leonie Durnin
Journal:  Pharmacol Ther       Date:  2014-06-02       Impact factor: 12.310

7.  Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.

Authors:  S A Lévesque; E G Lavoie; J Lecka; F Bigonnesse; J Sévigny
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.